Mannatech Stock Coverage Initiated by StockNews.com with a 'Buy' Rating

Recent developments in the financial world include the initiation of coverage on Mannatech by StockNews.com. On a Wednesday report, StockNews.com began analyzing the shares of Mannatech (NASDAQ:MTEX) and assigned a 'buy' rating to the company's stock, indicating a positive outlook.

Mannatech Stock Experiences a Dip

On the day the coverage was announced, Mannatech's stock opened at $8.66. Despite the fluctuations, Mannatech's financials show a debt-to-equity ratio of 0.10. The company also maintains liquidity with a quick ratio of 0.50 and a current ratio of 1.09. Over the past year, the stock has seen a low of $7.50 and a peak of $21.23. With a market cap of roughly $16.11 million and a P/E ratio of -2.14, Mannatech exhibits a beta of 1.22, adding to its investment profile, the average pricing for the past 50 and 200 days standing at $8.78 and $9.67 respectively.

Shifts in Institutional Ownership

In a notable recent transaction, LSV Asset Management significantly increased its holdings in Mannatech by 1,090.3% in the first quarter. This was revealed in the latest SEC filings where LSV Asset Management's purchase rose their share ownership to 7,142, which accounted for 0.37% of the company, valued at approximately $261,000. Overall, institutional investors and hedge funds possess 24.31% of Mannatech's floating stock.

About Mannatech

Mannatech, Incorporated is a global player in the health and wellness sector. The company is dedicated to the creation, marketing, and sales of a variety of products that include nutritional supplements, skin care, and anti-aging products, as well as items aimed at weight-management and fitness. Mannatech primarily distributes its products through direct sales, e-commerce, and network marketing channels, embracing a multi-channel approach to reaching customers.

Mannatech, Coverage, Stocks